1. Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review

   • Beatriz Oda Plasencia-García
   • Gonzalo Rodríguez-Menéndez
   • Benedicto Crespo-Facorro

   Review 07 January 2021 Pages: 329 - 340

2. Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

   • Nicole L. Galvão-Coelho
   • Wolfgang Marx
   • Jerome Sarris

   Review Open access 11 January 2021 Pages: 341 - 354

   

3. Nicotine sensitization (part 1): estradiol or tamoxifen is required during the induction phase and not the expression phase to enable locomotor sensitization to nicotine in female rats

   • Jennet L. Baumbach
   • Cheryl M. McCormick

   Original Investigation 01 November 2020 Pages: 355 - 370

   

4. Nicotine sensitization (Part 2): Time spent in the centre of an open field sensitizes to repeated nicotine into the drug-free state in female rats

   • Jennet L. Baumbach
   • Cheryl M. McCormick

   Original Investigation 29 October 2020 Pages: 371 - 382

   

5. Sequential reversal learning: a new touchscreen schedule for assessing cognitive flexibility in mice

   • Anna U. Odland
   • Rune Sandahl
   • Jesper T. Andreasen

   Original Investigation 30 October 2020 Pages: 383 - 397

   

6. Temporal discounting and smoking cessation: choice consistency predicts nicotine abstinence in treatment-seeking smokers

   • Charlotte M. Grosskopf
   • Nils B. Kroemer
   • Michael N. Smolka

   Original Investigation Open access 20 November 2020 Pages: 399 - 410

   

7. Increased negative affect when combining early-life maternal deprivation with adolescent, but not adult, cocaine exposure in male rats: regulation of hippocampal FADD

   • Cristian Bis-Humbert
   • Rubén García-Cabrerizo
   • M. Julia García-Fuster

   Original Investigation 27 October 2020 Pages: 411 - 420

   

8. Rottlerin, BDNF, and the impairment of inhibitory avoidance memory

   • Wan-Ling Huang
   • Ming-Heng Hsiung
   • Sherry Shu-Jung Hu

   Original Investigation 04 November 2020 Pages: 421 - 439

   

9. Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine

   • Dimitris Repantis
   • Leonore Bovy
   • Martin Dresler

   Original Investigation Open access 17 November 2020 Pages: 441 - 451

   

10. Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial

    • Richard J. Zeifman
    • Nikhita Singhal
    • Cory R. Weissman

    Original Investigation 29 October 2020 Pages: 453 - 459

    

11. Intranasal oxytocin decreases self-oriented learning

    • Zhijun Liao
    • Liqin Huang
    • Siyang Luo

    Original Investigation 06 November 2020 Pages: 461 - 474

    

12. Nicotine-induced enhancement of a sensory reinforcer in adult rats: antagonist pretreatment effects

    • Doran J. Satanove
    • Simon Rahman
    • Paul B. S. Clarke

    Original Investigation 04 November 2020 Pages: 475 - 486

    

13. Sigma-1 receptor ligands improves ventricular repolarization-related ion remodeling in rats with major depression disorder

    • Yan Guo
    • Cui Zhang
    • Bo Yang

    Original Investigation 02 November 2020 Pages: 487 - 499

    

14. Carnosic acid alleviates depression-like behaviors on chronic mild stressed mice via PPAR-γ-dependent regulation of ADPN/FGF9 pathway

    • Xiao-qing Wang
    • Ya-hui Tang
    • De-Jian Jiang

    Original Investigation 07 November 2020 Pages: 501 - 516

    

15. Neonatal phencyclidine and social isolation in the rat: effects of clozapine on locomotor activity, social recognition, prepulse inhibition, and executive functions deficits

    • Al Mahdy Hamieh
    • David Babin
    • Vincent Castagné

    Original Investigation 09 November 2020 Pages: 517 - 528

    

16. No differences in delay discounting between smokers with and without HIV

    • Cory Czuczman
    • Morgan Thompson
    • Rebecca L. Ashare

    Original Investigation 12 November 2020 Pages: 529 - 537

    

17. Acute administration of oxycodone, alcohol, and their combination on simulated driving—preliminary outcomes in healthy adults

    • Shanna Babalonis
    • Marion A. Coe
    • Sharon L. Walsh

    Original Investigation 09 November 2020 Pages: 539 - 549

    

18. Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210

    • Antonia Serrano
    • Evelyn Vadas
    • Fernando Rodríguez de Fonseca

    Original Investigation 07 January 2021 Pages: 551 - 557

    

19. Ketamine reduces temporal expectation in the rhesus monkey

    • Sophie Brulé
    • Bastien Herlin
    • Marcus Missal

    Original Investigation 09 November 2020 Pages: 559 - 567

    

20. Propofol but not dexmedetomidine produce locomotor sensitization via nitric oxide in rats

    • Tuğçe Uskur
    • Ayşe Özçetin Şenöz
    • Tayfun Uzbay

    Original Investigation 09 November 2020 Pages: 569 - 577

    

21. Correction to: Propofol but not dexmedetomidine produce locomotor sensitization via nitric oxide in rats

    • Tuğçe Uskur
    • Ayşe Özçetin Şenöz
    • Tayfun Uzbay

    Correction 20 November 2020 Pages: 579 - 579

22. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

    • Allison A. Feduccia
    • Lisa Jerome
    • Julie Holland

    Original Investigation Open access 21 November 2020 Pages: 581 - 588

23. Nicotinic receptor modulation of the default mode network

    • Britta Hahn
    • Alexander N. Harvey
    • Elliot A. Stein

    Original Investigation 20 November 2020 Pages: 589 - 597

    

24. The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure

    • Schuyler C. Lawson
    • Julie C. Gass
    • Larry W. Hawk Jr

    Original Investigation 21 November 2020 Pages: 599 - 609

    

25. Fluvoxamine, melatonin and COVID-19

    • George M. Anderson

    Letter to the Editor 04 January 2021 Pages: 611 - 611

26. Is the decrease in NO_x due to a lack of substrate or a NOS inhibition in patients with major depression?

    • E. Loeb
    • L. Becquemont
    • E. Corruble

    Commentary 09 January 2021 Pages: 613 - 614